21st International Congress of Cardiovascular Updates

The meeting the Scientific Committee of the 21st International Congress of Cardiovascular Updates The meeting panel of the Scientific Committee of the 21ST International Congress of Cardiovascular Updates was held in Espinas Palace Hotel with participation specialist of different cardiology fields including imaging, intervention, surgery and electrophysiology . On this occasion the Congress’ policy and the scientific program was set on the basis of latest research and scientific achievements in the field of cardiology. The agenda for this congress was decided to be on the core of: A review on the latest guidelines, pathways in the diagnosis and treatment of cardiovascular diseases, the use of advanced diagnostic tools in cardiovascular diseases such as angiography, MRI, CT angiography, echocardiography and nuclear examination. Also diagnosis of heart rate disorders including cardiac arrhythmias (based on ECG), the latest achievements in the replacement or Aorta without surgery (TAVI) and the last generation of heart medical treatments were added as the main topics of this congress. In addition to the in-depth discussions on the topics mentioned, members of each panel emphasized on the necessary elements that increase the willingness of participants to attend and participate in the meetings. . Participants were mostly faculty members from the universities of medical sciences and prominent cardiologists from national healthcare system. By reviewing the latest results of international and national congresses around the world, their comparisons, as well as the strengths and weaknesses, all members were committed to hold this year’s congress in the best quality. The meeting was ended with emphasis on increasing the likelihood of specialist and member’s strong association, in particular with regard to setting further presentations in the congress It should be noted that this meeting was held on 10.04.2019 at the Spinase Palace Hotel, Tehran with close cooperation of Iranian Society of Atherosclerosis and the Phfizer Pharmaceuticals Company.

For more information, please contact congress.iranathero.ir or the Secretariat of the Iranian Association for Atherosclerosis 021 223 877 06.